share_log

中国健康科技集团(01069)与斯库拉签署战略合作备忘录,合作共同在中国发展人参萃取离子能量水研发、销售的业务

China Health Technology Group (01069) and Scura signed a strategic cooperation memorandum to jointly develop the R&D and sales business of ginseng extracted ion energy water in China

Zhitong Finance ·  May 16 22:30

China Health Technology Group (01069) announced that on May 16, 2024, the company and Fujian Ningdes...

Zhitong Finance App News, China Health Technology Group (01069) announced that on May 16, 2024, the company and Fujian Ningdescura Technology Co., Ltd. (SCULA) signed a non-legally binding strategic cooperation memorandum of cooperation. According to the memorandum of strategic cooperation, the two sides agreed to cooperate to jointly develop a business (cooperative business) related to R&D and sales of ginseng extracted ion energy water in China.

According to the Memorandum of Strategic Cooperation, in order to jointly develop cooperative business, the company has the advantage of ginseng cultivation and sales business, and will strengthen exchanges and collaboration with Scura in various aspects such as the development and sale of ginseng extraction technology to complement each other.

The board of directors believes that the signing of a memorandum of strategic cooperation between the Group and Scura will help the Group develop ginseng cultivation and ginseng deep processing business. This business activity can enhance the financial performance and profitability of the Group. The Board believes that the development of new business activities will be in the overall interest of the company and its shareholders.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment